Chen-Chang Lee

Title: Innovations of Chen-Chang Lee

Introduction

Chen-Chang Lee is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for drug delivery systems. With a total of two patents to his name, his work focuses on enhancing the stability and bioavailability of therapeutic agents.

Latest Patents

One of his latest patents is titled "Pharmaceutical composition for sustained release delivery of buprenorphine." This invention is directed to a depot composition that allows for sustained release delivery of buprenorphine, providing enhanced stability and bioavailability. The composition is designed as an injectable, low viscosity liquid that can form a depot in situ, capable of delivering therapeutic levels of buprenorphine over a period ranging from one week to three months. Another significant patent is related to "Esters of dihydrotetrabenazine." This invention involves a compound that includes various stereochemically isomeric forms or pharmaceutically acceptable salts, focusing on the structural diversity of alkyl esters.

Career Highlights

Chen-Chang Lee is currently associated with Foresee Pharmaceuticals Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving drug delivery methods and enhancing patient outcomes through advanced formulations.

Collaborations

He collaborates with talented coworkers, including Yuhua Li and Wen-Yen Huang, who contribute to the research and development efforts at Foresee Pharmaceuticals Co., Ltd.

Conclusion

Chen-Chang Lee's contributions to pharmaceutical innovations demonstrate his dedication to advancing drug delivery systems. His patents reflect a deep understanding of the complexities involved in pharmaceutical compositions, paving the way for improved therapeutic options.